Company page

Bionime Corporation

Bionime Corporation, trading under the ticker 4737, is a publicly listed company on the Taiwan market with a market capitalization of approximately 135.15 million USD. The company specializes in developing and manufacturing medical devices, particularly focusing on blood glucose monitoring systems. Bionime is committed to enhancing diabetes management through innovative technology and reliable products.